Need a specific person's email?
Browse Oncternal Therapeutics's employee directory (about 6 employees) and reveal verified emails free.
Oncternal Therapeutics's most common email format is FLast@oncternal.com (ex. JDoe@oncternal.com), used for 82% of oncternal.com addresses. Oncternal Therapeutics uses 4 email patterns.
| Format | Example | Share of oncternal.com |
|---|---|---|
| FLast@oncternal.comMost common | JDoe@oncternal.com | |
| Last@oncternal.com | Doe@oncternal.com | |
| First_Last@oncternal.com | John_Doe@oncternal.com | |
| LastFir@oncternal.com | DoeJoh@oncternal.com |
Browse Oncternal Therapeutics's employee directory (about 6 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States2-10 Employees
Oncternal Therapeutics is a clinical-stage biotechnology company focused on oncology research, headquartered at 12230 El Camino Real, Suite 300, San Diego, California 92130, United States. The company pursues a diverse pipeline targeting cancer pathways that are not yet fully exploited, with the aim of addressing cancers with unmet medical need. Its programs include cirmtuzumab, a monoclonal antibody in Phase 1/2 that targets the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 that inhibits ETS-family oncoproteins for Ewing sarcoma; and a ROR1-targeting CAR-T therapy in preclinical development for solid tumors and hematologic cancers. The company employs a small team, with 2 to 10 employees, and maintains its online presence at oncternal.com. Funding has been reported at about $86 million.
Most common format
FLast@oncternal.com
Example: JDoe@oncternal.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.